Dbv Technologies reported $-0.18 in EPS Earnings Per Share for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Eps Change
Acadia Pharmaceuticals ACAD:US USD 0 0
Alnylam Pharmaceuticals ALNY:US USD -2.69 0.4
Amarin AMRN:US USD -0.01 0.1
Biocryst Pharmaceuticals BCRX:US USD -0.23 0.09
Biomarin Pharmaceutical BMRN:US USD -0.04 0.19
Dbv Technologies DBVT:US USD -0.18 0.15
Esperion Therapeutics ESPR:US USD -0.81 0.24
Galectin Therapeutics GALT:US USD -0.14 0.02
Halozyme Therapeutics HALO:US USD 0.74 0.21
Insmed INSM:US USD -1.09 0.29
Intercept Pharmaceuticals ICPT:US USD 7.8 8.48
Neurocrine Biosciences NBIX:US USD 0.69 0.87
Ptc Therapeutics PTCT:US USD -1.53 0.6
Sarepta Therapeutics SRPT:US USD -2.94 0.29
Ultragenyx Pharmaceutical RARE:US USD -3.5 1.24
United Therapeutics UTHR:US USD 4.91 2.5
YTE INCY:US USD 0.6 0.41